Loading data for UPC — first visit, this takes a few seconds.
Universe Pharmaceuticals INC (UPC)
NasdaqCM: UPC
· 即時價格 · USD
5.00
+0.31 (6.61%)
收盤價： Sep 02, 2026, 4:33 PM
股價、關鍵數字和最新消息，都在這一頁。
Universe Pharmaceuticals INC（UPC）股價、分析與資料
無可用資料
| 買價 | 3.55 |
| 市值 | 3.12M |
| 營收 (ttm) | 17.7M |
| 淨利（ttm） | -1.94M |
| 1.53 | |
| -1.38 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.05 |
| P/S (ttm) | 0.18 |
| 財報日期 | n/a |
| 賣價 | 6.11 |
| 成交量 | 6,848 |
| 20 日平均成交量 | 2,083,685 |
| 開盤價 | 4.78 |
| 前收盤價 | 4.69 |
| 當日區間 | 4.74 - 5.00 |
| 52 週範圍 | 2.00 - 17.96 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 UPC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qian...
完整的公司簡介財務表現
Universe Pharmaceuticals INC 在 2025 年的營收為 17.86M，較前一年的 23.02M 減少 -22.44%。 淨利為 -3.67M，較前期減少 -57.92%。
財務報表財報驚奇
Universe Pharmaceuticals INC 已於 Invalid Date 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 低於預期 , 年增 NaN% 成長.
